Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 91

Sort by

Sort Order Select

Journal Articles

SCD MED ALERT, a Novel mHealth for Acute Pain Management, Contributes to the Empowerment of Patients with Sickle Cell Disease

Simone Villaboni, Barbara Gianesin, Maddalena Casale, Silverio Perrotta, Filippo Mazzi, Jacopo Ceolan, Roberto Pirrone, Antonia Gigante, Valeria Maria Pinto, Michaela Calvillo, Raffaella Origa, Gian Luca Forni, Lucia De Franceschi

Blood (2024) 144 (Supplement 1): 1140.

https://doi.org/10.1182/blood-2024-200628

Published: 2024

Journal Articles

Single-Cell Transcriptomic Analysis of Bone Marrow from Humanized Sickle Cell Mice Reveals a Subpopulation of Highly-Expressing S100A8/A9 Mesenchymal Stem Cells

Jacopo Ceolan, Petros Kolovos, Enrica Federti, Panagiotis Liakopoulos, Veronica Riccardi, Immacolata Andolfo, Alessandro Mattè, Roberta Russo, Achille Iolascon, Helene Gleitz, Sjaak Philipsen, Lucia De Franceschi

Blood (2024) 144 (Supplement 1): 3867.

https://doi.org/10.1182/blood-2024-209911

Published: 2024

Journal Articles

Pregnancy and Childbirth in Women with Thalassemia: Past and Present

Blood (2024) 144 (Supplement 1): 3859.

https://doi.org/10.1182/blood-2024-202949

Published: 2024

Journal Articles

Exploring Muscular Senescence in Transfusion-Dependent Thalassemia without Cardiac Iron Overload: Roles of FGF21, ICAM1 and Post-Exercise Pulmonary Congestion

Mattia Cominacini, Enrica Federti, Sofia Menotti, Martino Donini, Jacopo Ceolan, Simone Villaboni, Filippo Mazzi, Gianluigi Dorelli, Maria Teresa Valenti, Luca Dalle Carbonare, Lucia De Franceschi, Michele Braggio

Blood (2024) 144 (Supplement 1): 3858.

https://doi.org/10.1182/blood-2024-204793

Published: 2024

Journal Articles

PIEZO1 Gain-of-Function Variants Lead to Alterations in Late-Stage Erythropoiesis By Enhancing Enucleation Rate

Barbara Eleni Rosato, Antonella Nostroso, Vanessa D'Onofrio, Roberta Marra, Federica Maria Esposito, Vincenza Cerbone, Lucia De Franceschi, Achille Iolascon, Roberta Russo, Immacolata Andolfo

Blood (2024) 144 (Supplement 1): 3837.

https://doi.org/10.1182/blood-2024-204705

Published: 2024

Journal Articles

pkm2 Binds to the Regulatory Regions of Gata-1 and stat5 in β-Thalassemic Mouse Erythroblasts

Enrica Federti, Silvia Pietrobono, Veronica Riccardi, Jacopo Ceolan, Richard Pozzetto Huot, Filippo Mazzi, Tolunay Kavaz, Immacolata Andolfo, Roberta Russo, Davide Melisi, Achille Iolascon, Lucia De Franceschi

Blood (2024) 144 (Supplement 1): 410.

https://doi.org/10.1182/blood-2024-203061

Published: 2024

Journal Articles

Novel therapeutic approaches in thalassemias, sickle cell disease, and other red cell disorders

Valeria Maria Pinto, Filippo Mazzi, Lucia De Franceschi

Blood (2024) 144 (8): 853–866.

https://doi.org/10.1182/blood.2023022193

Published: 2024

Includes: Supplemental data

Journal Articles

An oral carbon monoxide–releasing molecule protects against acute hyperhemolysis in sickle cell disease

Kim Anh Nguyen, Alessandro Matte, Roberta Foresti, Enrica Federti, Laurent Kiger, Cécile Lefebvre, Hakim Hocini, Yanis Pelinski, Hiroaki Kitagishi, Laura Bencheikh, France Pirenne, Lucia de Franceschi, Roberto Motterlini, Pablo Bartolucci

Blood (2024) 143 (24): 2544–2558.

https://doi.org/10.1182/blood.2023023165

Published: 2024

Includes: Supplemental data

Journal Articles

Mitapivat Treatment Increases β-Thalassemic Erythroblasts Energy Production and Responsiveness to Oxidative Stress

Alessandro Mattè, Angelo D'Alessandro, Mariarita Bertoldi, Richard Huot Pozzetto, Giovanni Bisello, Andrea Mattarei, Alberto Ongaro, Alice Passarini, Angela Siciliano, Roberta Russo, Achille Iolascon, Carlo Brugnara, Lucia De Franceschi

Blood (2023) 142 (Supplement 1): 3850.

https://doi.org/10.1182/blood-2023-185681

Published: 2023

Journal Articles

Trials in Progress: The Randomized, Double-Blind, Placebo-Controlled Phase 1b CROSSWALK-a and Phase 2a CROSSWALK-c Trials - Crovalimab for the Treatment and Prevention of Vaso-Occlusive Episodes in Sickle Cell Disease

Marco Aurelio Salvino, Bulent Antmen, Frederick Chite Asirwa, Satheesh Chonat, Lucia De Franceschi, Perla Eleftheriou, Adlette Inati, Johnny Mahlangu, Erfan Nur, Salvador Payán-Pernía, Asad Charania, Diana Gradinaru, Allison Hsia, Yves Luder, Thomas Perretti, Sasha Srekovic, Pablo Bartolucci

Blood (2023) 142 (Supplement 1): 1158.

https://doi.org/10.1182/blood-2023-179858

Published: 2023

Journal Articles

17R-Resolvin D1 Improves Inflammatory Cardiomyopathy in a Mouse Model of Sickle Cell Disease

Enrica Federti, Domenico Mattoscio, Antonio Recchiuti, Alessandro Mattè, Maria Monti, Flora Cozzolino, Martina Ceci, Manuela Iezzi, Angela Siciliano, Veronica Riccardi, Alice Passarini, Carlo Brugnara, Lucia De Franceschi

Blood (2023) 142 (Supplement 1): 2496.

https://doi.org/10.1182/blood-2023-185603

Published: 2023

Journal Articles

Luspatercept in the Treatment of Beta Thalassemia in Italy: Lights and Shadows in Clinical Practice

Blood (2023) 142 (Supplement 1): 2475.

https://doi.org/10.1182/blood-2023-179747

Published: 2023

Journal Articles

Unraveling the Role of PIEZO1 in Stressed Erythropoiesis: Implications for Dyserythropoiesis and Potential Therapeutic Targets in Dehydrated Hereditary Stomatocytosis

Barbara Eleni Rosato, Vanessa D'Onofrio, Antonella Nostroso, Roberta Marra, Federica Maria Esposito, Maddalena Raia, Giuseppe D'Alterio, Mario Capasso, Lucia De Franceschi, Achille Iolascon, Roberta Russo, Immacolata Andolfo

Blood (2023) 142 (Supplement 1): 2446.

https://doi.org/10.1182/blood-2023-180833

Published: 2023

Journal Articles

Colchicine Protects Against Cardiomyopathy in Humanized Mouse Model for Sickle Cell Disease

Enrica Federti, Iana Iatcenko, Alessandra Ghigo, Alessandro Mattè, Veronica Riccardi, Immacolata Andolfo, Angela Siciliano, Filippo Mazzi, Manuela Stella, Luigi Robbiano, Valeria Pinto, Achille Iolascon, Gian Luca Forni, Lucia De Franceschi

Blood (2022) 140 (Supplement 1): 2513–2514.

https://doi.org/10.1182/blood-2022-163037

Published: 2022

Journal Articles

Resolvins Modulate Netosis and Autoimmunity in Sickle Cell Disease

Alessandro Mattè, Antonio Recchiuti, Enrica Federti, Filippo Mazzi, Jacopo Ceolan, Annamaria Porreca, Marta Di Nicola, Sofia Menotti, Stefano Alivernini, Carlo Brugnara, Lucia De Franceschi

Blood (2022) 140 (Supplement 1): 5399–5400.

https://doi.org/10.1182/blood-2022-166240

Published: 2022

Journal Articles

Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-thalassemia: role of an additional dose

Blood (2022) 140 (15): 1735–1738.

https://doi.org/10.1182/blood.2022017594

Published: 2022

Includes: Supplemental data

Journal Articles

The Increased Burden of Sickle Cell Disease in Italy: Findings from the Greatalys (Generating Real world Evidence Across ITALy In SCD) Study

Lucia de Franceschi, Gian Luca Forni, Chiara Castiglioni, Claudia Condorelli, Diletta Valsecchi, Eleonora Premoli, Valentina Perrone, Luca Degli Esposti, Carina Andrea Fiocchi

Blood (2021) 138 (Supplement 1): 1950.

https://doi.org/10.1182/blood-2021-148273

Published: 2021

Journal Articles

Nrf2 Plays a Key Role in Iron-Overload Cardiomyopathy

Enrica Federti, Francesca Vinchi, Iana Iatcenko, Alessandra Ghigo, Alessandro Mattè, Serge Cedrick, Angela Siciliano, Deborah Chiabrando, Emanuela Tolosano, S. Zebulon Vance, Veronica Riccardi, Immacolata Andolfo, Achille Iolascon, Lucia de Franceschi

Blood (2021) 138 (Supplement 1): 3068.

https://doi.org/10.1182/blood-2021-146157

Published: 2021

Journal Articles

Trial in Progress: The Randomized, Double-Blind, Placebo-Controlled Phase IIa CROSSWALK-c Trial Evaluating the Efficacy of Crovalimab As Adjunct Treatment in the Prevention of Vaso-Occlusive Episodes (VOEs) in Patients with Sickle Cell Disease (SCD)

Michael Callaghan, Kenneth I. Ataga, Lucia De Franceschi, Caterina Minniti, Nadiesh Balachandran, Diane-Charlotte Imbs, Thomas Perretti, Julia Ramos, Alexandre Sostelly, Pablo Bartolucci

Blood (2021) 138 (Supplement 1): 3111.

https://doi.org/10.1182/blood-2021-151222

Published: 2021

Journal Articles

Trial in Progress: The Randomized, Double-Blind, Placebo-Controlled Phase Ib CROSSWALK-a Trial Evaluating the Safety of Crovalimab for the Management of Acute Uncomplicated Vaso-Occlusive Episodes (VOEs) in Patients with Sickle Cell Disease (SCD)

Pablo Bartolucci, Kenneth I. Ataga, Michael U. Callaghan, Lucia De Franceschi, Caterina Minniti, Ari Alexandrou, Diane-Charlotte Imbs, Richard Fox, Himika Patel, Alexandre Sostelly, Jonathan Schimmel

Blood (2021) 138 (Supplement 1): 3108.

https://doi.org/10.1182/blood-2021-147854

Published: 2021

NARROW

SCD MED ALERT, a Novel mHealth for Acute Pain Management, Contributes to the Empowerment of Patients with Sickle Cell Disease

Single-Cell Transcriptomic Analysis of Bone Marrow from Humanized Sickle Cell Mice Reveals a Subpopulation of Highly-Expressing S100A8/A9 Mesenchymal Stem Cells

Pregnancy and Childbirth in Women with Thalassemia: Past and Present

Exploring Muscular Senescence in Transfusion-Dependent Thalassemia without Cardiac Iron Overload: Roles of FGF21, ICAM1 and Post-Exercise Pulmonary Congestion

PIEZO1 Gain-of-Function Variants Lead to Alterations in Late-Stage Erythropoiesis By Enhancing Enucleation Rate

pkm2 Binds to the Regulatory Regions of Gata-1 and stat5 in β-Thalassemic Mouse Erythroblasts

Novel therapeutic approaches in thalassemias, sickle cell disease, and other red cell disorders

An oral carbon monoxide–releasing molecule protects against acute hyperhemolysis in sickle cell disease

Mitapivat Treatment Increases β-Thalassemic Erythroblasts Energy Production and Responsiveness to Oxidative Stress

Trials in Progress: The Randomized, Double-Blind, Placebo-Controlled Phase 1b CROSSWALK-a and Phase 2a CROSSWALK-c Trials - Crovalimab for the Treatment and Prevention of Vaso-Occlusive Episodes in Sickle Cell Disease

17R-Resolvin D1 Improves Inflammatory Cardiomyopathy in a Mouse Model of Sickle Cell Disease

Luspatercept in the Treatment of Beta Thalassemia in Italy: Lights and Shadows in Clinical Practice

Unraveling the Role of PIEZO1 in Stressed Erythropoiesis: Implications for Dyserythropoiesis and Potential Therapeutic Targets in Dehydrated Hereditary Stomatocytosis

Colchicine Protects Against Cardiomyopathy in Humanized Mouse Model for Sickle Cell Disease

Resolvins Modulate Netosis and Autoimmunity in Sickle Cell Disease

Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-thalassemia: role of an additional dose

The Increased Burden of Sickle Cell Disease in Italy: Findings from the Greatalys (Generating Real world Evidence Across ITALy In SCD) Study

Nrf2 Plays a Key Role in Iron-Overload Cardiomyopathy

Trial in Progress: The Randomized, Double-Blind, Placebo-Controlled Phase IIa CROSSWALK-c Trial Evaluating the Efficacy of Crovalimab As Adjunct Treatment in the Prevention of Vaso-Occlusive Episodes (VOEs) in Patients with Sickle Cell Disease (SCD)

Trial in Progress: The Randomized, Double-Blind, Placebo-Controlled Phase Ib CROSSWALK-a Trial Evaluating the Safety of Crovalimab for the Management of Acute Uncomplicated Vaso-Occlusive Episodes (VOEs) in Patients with Sickle Cell Disease (SCD)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only